Time-trends in thrombolytics: Women are catching up

Scandinavian Cardiovascular Journal

Volumn 33, Issue 1, 1999, Pages 39-43

  Johanson, Per ^a   Abrahamssori, P ^a   Rosengren, A ^a   Dellborg, M ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute myocardial infarction; Gender; Thrombolytics; Time trend

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LOGISTIC MODELS; MALE; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SEX FACTORS; STATISTICS, NONPARAMETRIC; SWEDEN; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0032812470     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017439950142028     Document Type: Article

References (31)

1. McLaughlin TJ, Soumerai SB, Willison DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med 1996; 156: 799-805.
2. Maynard C, Litwin PE, Martin JS, Weaver WD. Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med 1992; 152): 972-976.
3. Kudenchuk PJ, Maynard C, Martin JS, Wirkus M, Weaver WD. Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women (the Myocardial Infarction Triage and Intervention Registry). Am J Cardiol 1996; 78: 9-14.
4. Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. European Secondary Prevention Study Group. Lancet 1996; 347: 1203-1207.
5. Maynard C, Althouse R, Cerqueira M, Olsufka M, Kennedy JW. Underutilization of thrombolytic therapy in eligible women with acute myocardial infarction. Am J Cardiol 1991; 68: 529-530.
6. Pashos CL, Normand SL, Garfinkle JB, Newhouse JP, Epstein AM, McNeil BJ. Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992. J Am Coll Cardiol 1994; 23: 1023-1030.
7. Steingart RM, Packer M, Hamm P, et al. Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N Engl J Med 1991; 325: 226-230.
8. Pagley PR, Yarzebski J, Goldberg R, et al. Gender differences in the treatment of patients with acute myocardial infarction. A multihospital, community-based perspective. Arch Intern Med 1993; 153: 625-629.
9. Yarzebski J, Col N, Pagley P, Savageau J, Gore J, Goldberg R. Gender differences and factors associated with the receipt of thrombolytic therapy in patients with acute myocardial infarction: a community-wide perspective. Am Heart J 1996; 131: 43-50.
10. Behar S, Abinader E, Caspi A, et al. Frequency of use of thrombolytic therapy in acute myocardial infarction in Israel. Am J Cardiol 1991; 68: 1291-1294.
11. Behar S, Gottlieb S, Hod H, et al. Influence of gender in the therapeutic management of patients with acute myocardial infarction in Israel. The Israeli Thrombolytic Survey Group. Am J Cardiol 1994; 73: 438-443.
12. Dellborg M, Swedberg K. Acute myocardial infarction: difference in the treatment between men and women. Quality Assurance in Health Care 1993; 5: 261-265.
13. Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Gruppo Italiano per lo Studio della Streptochi-nasi nell'Infarto Miocardico (GISSI). Lancet 1987; 2(8564): 871-874.
14. Becker RC. Coronary thrombolysis in women. Cardiology 1990; 2: 110-123.
15. Topol EJ, Califf RM, George BS, Kereiakes DJ, Lee KL. Insights derived from the thrombolysis and angioplasty in myocardial infarction (TAMI) trials. J Am Coll Cardiol 1988; 12 Suppl 6A): 24A-31A.
16. Loukinen K, O'Neill W, Laufer N. Myocardial rupture complicating tissue plasminogen activator therapy of acute myocardial infarction. J Am Coll Cardiol 1989; 13 Suppl A: 94A.
17. George B, Candela R, Frazier R, et al. The paradox of high success of thrombolytic therapy and poor clinical outcome in elderly women with acute myccardial infarction. Circulation 1988; 78 Suppl II: II-211.
18. Califf RM, Stump D, Topol EJ. Overview of bleeding risk from the TAMI trials: two agents are better than one. J Am Coll Cardiol 1989; 13 2 Suppl A: 198A.
19. Lincoff AM, Califf RM, Ellis SG, et al. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group. J Am Coll Cardiol 1993; 22: 1780-1787.
20. Gurwitz JH, Goldberg RJ, Gore JM. Coronary thrombolysis for the elderly? JAMA 1991; 265: 1720-1723.
21. Rosamond WD, Shahar E, McGovern PG, Sides TL, Luepker RV. Trends in coronary thrombolytic therapy for acute myocardial infarction (the Minnesota Heart Survey Registry, 1990 to 1993). Am J Cardiol 1996; 78: 271-277.
22. Gurwitz JH, Gore JM, Goldberg RJ, Rubison M, Chandra N, Rogers WJ. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. National Registry of Myocardial Infarction. Ann Intern Med 1996; 124: 283-291.
23. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISS). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. I). Lancet 1986; 1(8478): 397-402.
24. Second International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2. Lancet 1988; 2(8607): 349-360.
25. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. [published erratum appears in Lancet 1994 Mar 19; 343(8899): 742]. Lancet 1994; 343(8893): 311-322.
26. Hennekens CH. Thrombolytic therapy: pre- and post-GISSI-2, ISIS-3, and GUSTO-1. Clin Cardiol 1994; 17 Suppl 1: 115-17.
27. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992; 268: 1417-1422.
28. Muller DW, Topol EJ. Selection of patients with acute myocardial infarction for thrombolytic therapy. Ann Intern Med 1990; 113: 949-960.
29. Dellborg M, Herlitz J, Emanuelsson H, Swedberg K. ECG changes during myocardial ischemia. Differences between men and women. J Electrocardiol 1994; 27: 42-45.
30. Tunstall-Pedoe H, Morrison C, Woodward M, Fitzpatrick B, Watt G. Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women. Circulation 1996; 93: 1981-1992.
31. Blohm M, Hartford M, Karlson BW, Karlsson T, Herlitz J. A media campaign aiming at reducing delay times and increasing the use of ambulance in AMI. Am J Emerg Med 1994; 12: 315-318.